Heritage Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Buy
272
+141
+108% +$90.4K 0.01% 224
2025
Q4
$88.6K Hold
131
﹤0.01% 272
2025
Q3
$83.7K Hold
131
﹤0.01% 262
2025
Q2
$70.3K Hold
131
﹤0.01% 277
2025
Q1
$55K Sell
131
-33
-20% -$14.3K ﹤0.01% 294
2024
Q4
$67.8K Hold
164
﹤0.01% 286
2024
Q3
$82.9K Hold
164
﹤0.01% 283
2024
Q2
$79.9K Sell
164
-34
-17% -$17.1K ﹤0.01% 268
2024
Q1
$107K Hold
198
﹤0.01% 257
2023
Q4
$110K Hold
198
0.01% 258
2023
Q3
$86.6K Hold
198
﹤0.01% 264
2023
Q2
$99.4K Sell
198
-35
-15% -$16.8K 0.01% 256
2023
Q1
$117K Hold
233
0.01% 245
2022
Q4
$95.1K Buy
233
+153
+191% +$59.4K 0.01% 267
2022
Q3
$26.1K Hold
80
﹤0.01% 355
2022
Q2
$28K Hold
80
﹤0.01% 381
2022
Q1
$44K Hold
80
﹤0.01% 329
2021
Q4
$53K Hold
80
﹤0.01% 326
2021
Q3
$49.8K Hold
80
﹤0.01% 318
2021
Q2
$50.5K Hold
80
﹤0.01% 324
2021
Q1
$39.1K Buy
+80
New +$40.1K ﹤0.01% 357

Other funds holding IDXX

Heritage Wealth Advisors's IDXX Position: Q1 2026 in Review

Heritage Wealth Advisors increased its Idexx Laboratories (IDXX) stake by 108% in Q1 2026, buying an estimated $90.4K and bringing the position to 272 shares worth $153K. The position accounts for 0.01% of the portfolio, ranked #224.

Heritage Wealth Advisors first reported a position in IDXX in Q1 2021 and has held it in 21 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Heritage Wealth Advisors held 272 shares of Idexx Laboratories worth $153K as of Q1 2026.
  • Heritage Wealth Advisors bought 141 Idexx Laboratories shares in Q1 2026, an estimated $90.4K.
  • Idexx Laboratories made up 0.01% of Heritage Wealth Advisors's portfolio in Q1 2026, its #224 holding.
  • Heritage Wealth Advisors first reported a position in Idexx Laboratories in Q1 2021 and has held it in 21 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Heritage Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.